Early Postoperative Results after Thymectomy for Thymic Cancer: A Single-Institution Experience.
Journal
World journal of surgery
ISSN: 1432-2323
Titre abrégé: World J Surg
Pays: United States
ID NLM: 7704052
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
accepted:
26
02
2023
medline:
3
7
2023
pubmed:
20
4
2023
entrez:
20
04
2023
Statut:
ppublish
Résumé
Surgery for thymic cancers is considered the key of curative treatment. Preoperative patients' characteristics and intraoperative features might influence postoperative outcome. We aim to verify short-term outcomes and possible risk factors for complications after thymectomy. We retrospectively investigated patients undergoing surgery for thymoma or thymic carcinoma in the period between January 1, 2008, and December 31, 2021, in our department. Preoperative features, surgical technique (open, bilateral VATS, RATS), intraoperative characteristics and incidence of postoperative complications (PC) were analyzed. We included in the study 138 patients. Open surgery was performed in 76 patients (55.1%), in 36 VATS (26.1%) and in 26 RATS (36.1%). Resection of one or more adjacent organs due to neoplastic infiltration was required in 25 patients. PC appeared in 25 patients (52% Clavien-Dindo grade I, 12% grade IVa). Open surgery had a higher incidence of PC (p < 0.001), longer postoperative in-hospital stay (p = 0.045) and larger neoplasm (p = 0.006). PC were significant related to pulmonary resection (p = 0.006), phrenic nerve resection (p = 0.029), resection of more than one organ (p = 0.009) and open surgery (p = 0.001), but only extended surgery of more organs was confirmed as independent prognostic factor for PC (p = 0.0013). Patients with preoperative myasthenia symptoms have a trend toward stage IVa complications (p = 0.065). No differences were observed between outcomes of VATS and RATS. Extended resections are related to a higher incidence of PC, while VATS and RATS guarantee a lower incidence of PC and shorter postoperative stay even in patients that require extended resections. Symptomatic myasthenia patients might have a higher risk toward more severe complications.
Sections du résumé
BACKGROUND
BACKGROUND
Surgery for thymic cancers is considered the key of curative treatment. Preoperative patients' characteristics and intraoperative features might influence postoperative outcome. We aim to verify short-term outcomes and possible risk factors for complications after thymectomy.
METHODS
METHODS
We retrospectively investigated patients undergoing surgery for thymoma or thymic carcinoma in the period between January 1, 2008, and December 31, 2021, in our department. Preoperative features, surgical technique (open, bilateral VATS, RATS), intraoperative characteristics and incidence of postoperative complications (PC) were analyzed.
RESULTS
RESULTS
We included in the study 138 patients. Open surgery was performed in 76 patients (55.1%), in 36 VATS (26.1%) and in 26 RATS (36.1%). Resection of one or more adjacent organs due to neoplastic infiltration was required in 25 patients. PC appeared in 25 patients (52% Clavien-Dindo grade I, 12% grade IVa). Open surgery had a higher incidence of PC (p < 0.001), longer postoperative in-hospital stay (p = 0.045) and larger neoplasm (p = 0.006). PC were significant related to pulmonary resection (p = 0.006), phrenic nerve resection (p = 0.029), resection of more than one organ (p = 0.009) and open surgery (p = 0.001), but only extended surgery of more organs was confirmed as independent prognostic factor for PC (p = 0.0013). Patients with preoperative myasthenia symptoms have a trend toward stage IVa complications (p = 0.065). No differences were observed between outcomes of VATS and RATS.
CONCLUSIONS
CONCLUSIONS
Extended resections are related to a higher incidence of PC, while VATS and RATS guarantee a lower incidence of PC and shorter postoperative stay even in patients that require extended resections. Symptomatic myasthenia patients might have a higher risk toward more severe complications.
Identifiants
pubmed: 37079104
doi: 10.1007/s00268-023-06996-5
pii: 10.1007/s00268-023-06996-5
pmc: PMC10310559
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1978-1985Informations de copyright
© 2023. The Author(s).
Références
Lancet Oncol. 2016 Jun;17(6):836-844
pubmed: 27160473
Eur J Cardiothorac Surg. 2019 Oct 01;56(4):762-769
pubmed: 31321412
Semin Thorac Cardiovasc Surg. 2023 Spring;35(1):189-199
pubmed: 34838953
Front Surg. 2022 Aug 08;9:860899
pubmed: 36034391
J Thorac Oncol. 2009 Dec;4(12):1561-7
pubmed: 19745769
Eur J Cardiothorac Surg. 2022 Aug 3;62(3):
pubmed: 35445251
Ann Cardiothorac Surg. 2019 Mar;8(2):174-193
pubmed: 31032201
Ann Thorac Surg. 2015 Sep;100(3):961-7
pubmed: 26163354
BMJ Open. 2019 Oct 14;9(10):e029507
pubmed: 31615795
J Laparoendosc Adv Surg Tech A. 2017 Jul;27(7):685-690
pubmed: 28121481
Crit Rev Oncol Hematol. 2016 Mar;99:332-50
pubmed: 26818050
Eur J Surg Oncol. 2016 Nov;42(11):1720-1728
pubmed: 27139936
Eur J Cardiothorac Surg. 2018 Sep 1;54(3):579-584
pubmed: 29547970
Ann Thorac Surg. 2021 Dec;112(6):1782-1789
pubmed: 33358889
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Ann Thorac Surg. 2019 Mar;107(3):878-884
pubmed: 30336118
J Robot Surg. 2018 Dec;12(4):719-724
pubmed: 29705833
Gland Surg. 2022 Mar;11(3):611-621
pubmed: 35402207
J Thorac Oncol. 2022 Nov;17(11):1258-1275
pubmed: 36031176
J Thorac Oncol. 2016 Jan;11(1):30-8
pubmed: 26762737
Am J Clin Oncol. 2016 Apr;39(2):120-5
pubmed: 24390276
J Thorac Cardiovasc Surg. 2020 Aug;160(2):555-567.e15
pubmed: 32245668
Eur J Cardiothorac Surg. 2021 Apr 29;59(4):807-813
pubmed: 33279991
Gen Thorac Cardiovasc Surg. 2018 Dec;66(12):731-735
pubmed: 30132223
Eur J Cardiothorac Surg. 2022 Aug 3;62(3):
pubmed: 35259241
Thorac Cancer. 2022 Jan;13(2):151-161
pubmed: 34806328
Interact Cardiovasc Thorac Surg. 2021 Aug 18;33(3):385-394
pubmed: 33997899
Asian J Surg. 2020 Jan;43(1):244-250
pubmed: 31047770
J Thorac Oncol. 2010 Oct;5(10 Suppl 4):S344-7
pubmed: 20859130
Transl Cancer Res. 2019 Jun;8(3):962-967
pubmed: 35116835